(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

TERAPIA DE CÉLULAS T COM RECEPTOR DE ANTÍGENO QUIMÉRICO

Em AnáliseInvention PatentPCT · US2020059285

Application data

Number

112022008514

Type

Invention Patent

Filing

11/06/2020

Publication

07/26/2022

PCT

US2020059285

Progress at the INPI

  1. Filing11/06/20
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 11/06/2020. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 04/30/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

KITE PHARMA, INC.

US

See this company's full portfolio

Inventors

A. B. (pessoa física)

US

J. R. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

62/931,636 · 11/06/2019

US

62/944,937 · 12/06/2019

US

63/031,217 · 05/28/2020

US

63/056,369 · 07/24/2020

US

63/063,692 · 08/10/2020

US

63/089,930 · 10/09/2020

Abstract

TERAPIA DE CÉLULAS T COM RECEPTOR DE ANTÍGENO QUIMÉRICO. São aqui fornecidos métodos para preparar, produzir, processar, cultivar, isolar ou produzir células adequadas para terapia imune ou celular, e para seu uso na terapia celular.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

15.50

O pedido foi dividido no BR122023023020-5 protocolo 870230097220 em 03/11/2023 13:22.

04/30/2024

RPI 2782

Notificação de entrada na fase nacional - PCT

#1.3

07/26/2022

RPI 2690

Alteração de dados cadastrais

#1.1

05/10/2022

RPI 2679

Related

From the same holder

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.